We are an international, multi-disciplinary expert group dedicated to increasing cervical cancer screening participation.

Professor Descamps is a Distinguished Professor of Obstetrics and Gynaecology and has been the Head of Obstetrics and Gynaecology at Angers University Hospital in France since 1999. He is also the Director of the Regional Reference Centre for Endometriosis, Endo Ref-Angers.

Professor Descamps is the Vice President of the International Federation of Gynaecology and Obstetrics (FIGO) and was elected as the French representative to the FIGO Council (2015 – 2021). He has sat on the Minimal Access Surgery Committee (2018 – 2021) and was a member of FIGO’s Strategic Planning Committee (2020 – 2021).

At a national level, he has supported the French National College of Gynaecologists and Obstetricians (CNGOF) by serving as the President of its International Relations Committee (2012 – present) and a member of its Board and Bureau (2005 – present). He was also the Vice President of the French Society of Gynaecological and Pelvic Surgery (SCGP) between 2011 and 2021.

Martin has a clinical background as a Qualified Nurse and Psychotherapist. He has been a Manager and Director in the NHS, Charitable and private sectors and is currently the Chief Executive of Jo’s Cervical Cancer Trust, based in London. He brings with him significant experience of working collaboratively across sectors in order to maximise reach and impact. Having recently had a close family member affected by cervical cancer, he also has personal passion to drive the movement towards the elimination of the disease across the world.

Dr. Bosch is a Senior Consultant for the Institute d’Investigació Biomèdica de Bellvitge (IDIBELL) as well as an Honorific Consultant to the Catalan Institute of Oncology (ICO) at Hospitalet de Llobregat in Barcelona, Spain. He is the founder of both the Papillomavirus Research (PVR) journal and the e-learning platform, www.eoncologia.net, specialising in e-courses on cervical cancer prevention.

Dr. Bosch’s epidemiological studies on cancers linked to infectious agents have played a catalytic role for the initiation of the vaccine trials and programs for HBV and HPV, as well as for the evaluation of HPV tests as screening tools. His interests now reside in sharing clinically important scientific information and in studies that integrate HPV vaccination and screening in environments with limited resources.

Dr. Bosch has published over 500 original publications, over 25 monograph books & major reviews, and has over 900 scientific communications at medical meetings.

Dr. Connolly is a General Practitioner with a special interest in gynaecology. She is a Royal College of General Practitioners (RCGP) women’s health clinical champion and Chair of Primary Care Women’s Health Forum (PCWHF).

She was the Royal College of the Obstetricians and Gynaecologists, Faculty of Family Planning and Reproductive Health Care (FSRH) VP (membership) from 2012-17 and is co-editor of Women’s Health in Primary Care.

Dr. Connolly was awarded an MBE for her work in women’s health in the 2021 Queens Birthday Honours List.

Professor Kyrgiou is a Consultant Gynaecologic Oncologist at the West London Gynaecological Cancer Centre in the UK. She completed her PhD Thesis and MSc in advanced gynaecological endoscopy.

Professor Kyrgiou also runs an independent research group and research programme at Imperial College London focusing on translational research in gynaecological cancers and clinical trials. She has authored 162 publications in peer-review journals, book chapters, and reviews. She has chaired both national and international meetings, including the European Society of Gynaecological Oncology (ESGO), the British Gynaecological Cancer Society (BGCS), and the International Federation of Cervical Pathology and Colposcopy (IFCPC), the European Federation of Colposcopy (EFC), International HPV Conference (workshop), the British Society for Colposcopy and Cervical Pathology (BSCCP), Canadian Association of Obstetricians and Gynaecologists (Quebec), International College of Outpatient Gynaecology (ICOG), The Royal College of Obstetricians & Gynaecologists (RCOG), and the Hellenic Society for Colposcopy and Cervical Pathology (HSCCP) in the UK, Ireland, Greece, France, Poland, and Canada.

Dr. Monsonego is a Gynaecologist based in Paris, France, where he specialises in colposcopy and in the management of HPV associated diseases.

He attended the Medical University of Paris and is the former Head of the Onco-Gynaecological and Breast Screening Unit (Paris Nord University, Department of Professor Lucien Israël – Bobigny). His institutional affiliations include Medical Director of Institut of the Cervix Paris, France; Member of the President and Founder of EUROGIN (European Research Organization on Genital Infection and Neoplasia); Expert Consultant on Cancer for the World Health Organization (WHO/OMS); and President of the international Women Against Cervical Cancer (WACC) Foundation.

Dr. Monsonego’s specialist areas of research include: Management of abnormal pap smear and papillomavirus infection, Cervical cancer screening and prevention, Colposcopy and treatment of genital papillomavirus lesions, Clinical trials of HPV vaccines, Prophylactic and therapeutic vaccines for human papillomavirus infections, Screening for cervical cancers, colposcopy, and drugs for the treatment of HPV-related lesions, and new technologies applied to cervical cancer screening and management, such as HPV DNA testing and genotyping, liquid-based cytology, real-time screening methods, and molecular markers.

Ody is an independent consultant and Public Affairs Advisor, with extensive working experience at WOMEN Inc. based in Amsterdam, Netherlands, where she works in a policy advisory role and is an advocate in the field of gender equality. She had also undertaken a similar role at UN Women and is currently a member of the European Economic and Social Committee (EESC) on behalf of gender equality and civil society, issuing consensus-based opinions on European legislation.

A former senior expert on women’s economic empowerment at UN Women, her areas of interest include governmental policy on employment and social affairs, human rights, and inclusivity.

Dr. Nguyen is the Director of Cytopathology at Unity Health Toronto, Canada. She is also an Assistant Professor and Associate Graduate Faculty Member at the University of Toronto. 

Dr. Nguyen is affiliated with several professional associations including the Canadian Association on Neuropathologists (CANP), Ontario Medical Association (OMA), and American Society of Cytopathology (ASC). She has been Vice-Chair of the Cytopathology Committee and Expert Advisor on the Quality Measures Technical Expert Panel for the College of American Pathologists (CAP). She is also an Expert Consultant to the European Hologic Cervical Health Advisory Board.

Dr. O’Connor is a researcher and ICE Postdoctoral Research Fellow at Trinity College Dublin and has been involved in CERVIVA, a multi-disciplinary research consortium investigating cervical cancer screening and HPV-associated diseases since 2009.

She has over 12 years of experience in planning, coordinating, and conducting research studies underpinned by behavioural science in cancer prevention. Much of her research has focused on understanding the psychological impact of cervical cancer screening on women.

She has collaborated with national and international stakeholders across diverse disciplines and institutions including the National Cancer Registry Ireland (NCRI), the University College Cork (UCC) and the National Cancer Control Programme (NCCP).

Dr. Smith is an Epidemiology Professor at the Gillings School of Global Public Health, North Carolina.

She is also affiliated with the UNC Lineberger Comprehensive Cancer Center, UNC Center for Aids Research, and the UNC Center for Women’s Health Research.

Additionally, Dr. Smith has conducted research on HPV infection and associated cervical neoplasia and cancer since 1995 and has published over 200 articles in international peer-reviewed journals. Her current research focuses on epidemiological studies of human papillomavirus (HPV) and cervical cancer worldwide (primarily in China, Kenya, South Africa, and North Carolina), with a focus on prevention via screening, HPV self-screening, and prophylactic vaccines.

Dr. Smith is currently conducting self-screening demonstration projects of HPV infection among high-risk women in Mombasa, Kenya, and in rural North Carolina.